Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor
Authors:
- 1 February 2008
- journal article
- Published by Springer Nature in Japanese Journal of Ophthalmology
- Vol. 52 (1) , 16-23
Abstract
Vascular endothelial growth factor (VEGF) plays a pivotal role in pathological angiogenesis. In this study, we addressed the therapeutic potential of fasudil, a potent Rho-kinase inhibitor, for VEGF-elicited angiogenesis and also for the intracellular signalings induced by VEGF. In vitro, the inhibitory effects of fasudil on the VEGF-dependent VEGF receptor 2 (VEFGR2 or KDR), extracellular signal-related kinase (ERK) 1/2, Akt and myosin light chain (MLC) phosphorylation, as well as on the migration and proliferation of bovine retinal microvascular endothelial cells (BRECs) were analyzed with Western blotting, [3H]-thymidine uptake, and modified Boyden chamber assay. VEGF-elicited in vivo angiogenesis was analyzed with a mouse corneal micropocket assay coembedded with or without fasudil. VEGF caused enhanced MLC phosphorylation of BRECs, which was almost completely attenuated by 10μM fasudil. VEGF-dependent phosphorylation of ERK1/2 and Akt were also partially but significantly attenuated by treatment with fasudil without affecting VEGFR2 (KDR) phosphorylation. Moreover, both VEGF-induced [3H]-thymidine uptake and the migration of BRECs were significantly inhibited in the presence of fasudil. Finally, VEGF-elicited angiogenesis in the corneal micropocket assay was potently attenuated by coembedding with fasudil (P < 0.01). These findings indicate that fasudil might have a therapeutic potential for ocular angiogenic diseases. The antiangiogenic effect of fasudil appears to be mediated through the blockade not only of Rho-kinase signaling but also of ERK and Akt signaling.Keywords
This publication has 35 references indexed in Scilit:
- Vasohibin is up‐regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularizationThe FASEB Journal, 2006
- EphrinA1 Inhibits Vascular Endothelial Growth Factor-Induced Intracellular Signaling and Suppresses Retinal Neovascularization and Blood-Retinal Barrier BreakdownThe American Journal of Pathology, 2006
- Inhibition of pathologic retinal neovascularization by -defensinsBlood, 2005
- HMG CoA reductase inhibition modulates VEGF‐induced endothelial cell hyperpermeability by preventing RhoA activation and myosin regulatory light chain phosphorylationThe FASEB Journal, 2005
- Inhibition of Rho-Kinase Attenuates Hypoxia-Induced Angiogenesis in the Pulmonary CirculationCirculation Research, 2005
- Rho-Kinase Inhibitor Improves Increased Vascular Resistance and Impaired Vasodilation of the Forearm in Patients With Heart FailureCirculation, 2005
- Rho‐kinase and myosin II activities are required for cell type and environment specific migrationGenes to Cells, 2005
- The Involvement of the Rho-Kinase Pathway and Its Regulation in Cytokine-Induced Collagen Gel Contraction by HyalocytesInvestigative Ophthalmology & Visual Science, 2004
- Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during AngiogenesisJournal of Cell Biology, 1998
- The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factorsCell, 1992